Conference Program
 
Atherosclerosis
The Artery Wall And Beyond
June 21-26, 2009
Tilton School
Tilton, NH

The 2009 Gordon Conference on Atherosclerosis will present cutting-edge research on the molecular, cellular, immunological, structural and therapeutic aspects of atherosclerotic plaque formation and regression. The Conference will feature a wide range of topics, such as macrophage subsets, vascular calcification, vascular progenitor cells, genetic regulation of lipid metabolism, nanotechnology for diagnosis and treatment of atherosclerosis, cardiac valve atherosclerosis, inflammatory mediators, systems biology, lesion dynamics and reversibility, and clinical translation to novel therapeutics. Invited speakers represent a variety of scientific disciplines, including biochemistry, lipid metabolism, molecular genetics, bioengineering, immunology, vascular biology, cell biology and imaging. The Conference will bring together a collection of investigators who are at the forefront of their field, and will provide opportunities for junior scientists and graduate students to present their work in poster format and exchange ideas with leaders in the field. Some poster presenters will be selected for short talks. The collegial atmosphere of this Conference, with programmed discussion sessions as well as opportunities for informal gatherings in the afternoons and evenings, provides an avenue for scientists from different disciplines to brainstorm and promotes cross-disciplinary collaborations in the various research areas represented.


Contributors

SUNDAY
2:00 pm - 9:00 pmArrival and Check-in (Office Closed 6:00 pm - 7:00 pm)
5:00 pmMeeting of Chairs and Discussion Leaders
6:00 pmDinner
7:30 pm - 7:45 pmWelcome / Introductory Comments by GRC Site Staff & Chairs
7:45 pm - 9:30 pmMacrophage Heterogeneity
Discussion Leader: Siamon Gordon (University of Oxford)
7:45 pm - 8:05 pm Frédéric Geissmann (Université René Descartes Paris V)
"Monocyte subsets and the immune response"
8:05 pm - 8:15 pm Discussion
8:15 pm - 8:35 pm Filip Swirski (Massachusetts General Hospital)
"Behavior of reservoir monocytes in inflammation"
8:35 pm - 8:45 pm Discussion
8:45 pm - 9:05 pm Siamon Gordon (University of Oxford)
"Heterogeneity of macrophage functions: Receptors and responses"
9:05 pm - 9:15 pm Discussion
9:15 pm - 9:25 pm Short Talk: Koka Motoyama (University of Washington)
"Hypercholesterolemia induces a unique subset of macrophage foam cells in ApoE -/- mice"
9:25 pm - 9:30 pm Discussion
9:30 pm Reception
MONDAY
7:30 am - 8:30 amBreakfast
9:00 am - 12:30 pmGenomics and Genetics of Atherosclerosis
Discussion Leader: Ruth McPherson (University of Ottawa Heart Institute)
9:00 am - 9:20 am Karen Mohlke (University of North Carolina, Chapel Hill) "Common genetic variants for lipids and other metabolic risk factors for cardiovascular disease"
9:20 am - 9:30 am Discussion
9:30 am - 9:50 am Sekar Kathiresan (Massachusetts General Hospital)
"Genetic basis for complex cardiovascular traits"
9:50 am - 10:00 am Discussion
10:00 am - 10:20 am Robert Hegele (Robarts Research Institute)
"Rare genomic variants and atherosclerosis"
10:20 am - 10:30 am Discussion
10:30 am Coffee Break / Group Photo
11:00 am - 11:20 am Bev Paigen (Jackson Laboratory)
"Health status of animal room affects atherosclerosis and mapping of genetic loci for atherosclerosis susceptibility in mice"
11:20 am - 11:30 am Discussion
11:30 am - 11:50 am Ruth McPherson (University of Ottawa Heart Institute)
"Functional analysis of CHD genetic variants"
11:50 am - 12:00 pm Discussion
12:00 pm - 12:10 pm Short Talk: Vladimir Reiser (Merck Research Laboratories)
"REPLICA Biobank - an archive of human atherosclerotic plaque samples for identification of genetic, molecular and imaging biomarkers associated with cardiovascular risks and plaque composition"
12:10 pm - 12:15 pm Discussion
12:15 pm - 12:25 pm Short Talk: Nehal Mehta (University of Pennsylvania)
"A novel GWAS atherosclerosis locus regulates plasma levels of CXCL12"
12:25 pm - 12:30 pm Discussion
12:30 pmLunch
1:30 pm - 4:00 pmFree Time
4:00 pm - 6:00 pmPoster Session I
6:00 pmDinner
7:30 pm - 9:30 pmStem Cells and Lineage Acquisition
Discussion Leader: Qingbo Xu (King's College London)
7:30 pm - 7:50 pm Qingbo Xu (King's College London)
"Stem cells in the pathogenesis of atherosclerosis"
7:50 pm - 8:00 pm Discussion
8:00 pm - 8:20 pm Yi Zhu (Peking University)
"AMPK in endothelial progenitor cell differentiation"
8:20 pm - 8:30 pm Discussion
8:30 pm - 8:50 pm Ann Canfield (University of Manchester)
"Perivascular stem cells"
8:50 pm - 9:00 pm Discussion
9:00 pm - 9:10 pm Short Talk: Isabel Casimiro (Albert Einstein College of Medicine)
"Impaired macrophage function in mice lacking allograft inflammatory factor-1 (AIF-1)"
9:10 pm - 9:15 pm Discussion
9:15 pm - 9:25 pm Short Talk: Gareth Hyde (University of Manchester)
"The regulation of VSMC adipogenic differentiation by Axl tyrosine kinase"
9:25 pm - 9:30 pm Discussion
9:30 pm Reception
TUESDAY
7:30 am - 8:30 amBreakfast
9:00 am - 12:30 pmCalcific vasculopathy and valvulopathy
Discussion Leader: Dwight Towler (Washington University)
9:00 am - 9:20 am Elena Aikawa (Massachusetts General Hospital)
"Molecular imaging of pro-inflammatory mechanisms of cardiovascular calcification"
9:20 am - 9:30 am Discussion
9:30 am - 9:50 am Robert Terkeltaub (University of California-San Diego)
"Ectoenzyme regulation of arterial calcification"
9:50 am - 10:00 am Discussion
10:00 am - 10:20 am Nalini Rajamannan (Northwestern University)
"The clinical spectrum of calcific aortic stenosis: Mediators and modifiers"
10:20 am - 10:30 am Discussion
10:30 am Coffee Break
11:00 am - 11:20 am Jordan Miller (University of Iowa)
"Oxidative stress & osteogenic signaling in valvular and vascular calcification"
11:20 am - 11:30 am Discussion
11:30 am - 11:50 am Catherine Shanahan (King's College London)
"Microparticles and nanoparticles in vascular calcification"
11:50 am - 12:00 pm Discussion
12:00 pm - 12:10 pm Short Talk: Wilhelm Jahnen-Dechent (RWTH Aachen University)
"Fetuin-A protects against atherosclerotic calcification in chronic kidney disease"
12:10 pm - 12:15 pm Discussion
12:15 pm - 12:25 pm Short Talk: Cindy Yip (University of Toronto)
"C-type natriuretic peptide protects valvular interstitial cells against pathological differentiation and calcification"
12:25 pm - 12:30 pm Discussion
12:30 pmLunch
1:30 pm - 4:00 pmFree Time
4:00 pm - 6:00 pmPoster Session I
6:00 pmDinner
7:30 pm - 9:30 pmFuture therapeutics and diagnostics: Nanotechnology and Atherosclerosis
Discussion Leader: Sam Wickline (Washington University)
7:30 pm - 7:50 pm Jeff Bulte (Johns Hopkins)
"Nanoparticles for cellular labeling and therapeutics"
7:50 pm - 8:00 pm Discussion
8:00 pm - 8:20 pm Sam Wickline (Washington University)
"Targeted theranostic nanoparticles for multiple clinical applications"
8:20 pm - 8:30 pm Discussion
8:30 pm - 8:50 pm Denis Buxton (National Institutes of Health)
"Nanobiology of atherosclerosis"
8:50 pm - 9:00 pm Discussion
9:00 pm - 9:10 pm Short Talk: Oscar Puig (Merck Research Laboratories)
"Identification of biomarkers of plaque status: Gene expression profiling of human atherosclerosis plaque"
9:10 pm - 9:15 pm Discussion
9:15 pm - 9:25 pm Short Talk: Bo Jansson (Bioinvent International)
"Oxidation-specific epitopes on LDL used as biomarkers for vulnerable plaques in atherosclerosis"
9:25 pm - 9:30 pm Discussion
9:30 pm Reception
WEDNESDAY
7:30 am - 8:30 amBreakfast
9:00 am - 12:30 pmLipids, Lipoproteins and Dysmetabolic Conditions
Discussion Leader: Stan Hazen (Cleveland Clinic)
9:00 am - 9:20 am Kerry-Anne Rye (University of Sydney)
"High Density Lipoproteins increase the insulin secretory capacity of pancreatic beta cells"
9:20 am - 9:30 am Discussion
9:30 am - 9:50 am Jonathan Smith (Cleveland Clinic)
"Inflammation impairs reverse cholesterol transport"
9:50 am - 10:00 am Discussion
10:00 am - 10:20 am Clay Semenkovich (Washington University)
"Novel approaches to insulin resistance and vascular disease"
10:20 am - 10:30 am Discussion
10:30 am Coffee Break
11:00 am - 11:20 am Theo Van Berkel (Leiden University)
"Macrophage cholesterol transporters and atherogenesis"
11:20 am - 11:30 am Discussion
11:30 am - 11:50 am Lisa Cassis (University of Kentucky)
"Effects of the low calorie sweetener, D-tagatose, vs sucrose on serum lipids in atherosclerotic mice and diabetic humans"
11:50 am - 12:00 pm Discussion
12:00 pm - 12:10 pm Short Talk: Longhue Fang (UCSD)
"Live imaging of oxidized lipoproteins in the vasculature of hypercholesterolemic zebrafish"
12:10 pm - 12:15 pm Discussion
12:15 pm - 12:25 pm Short Talk: Muredach Reilly (University of Pennsylvania)
"Adipocyte modulation of high-density lipoprotein cholesterol"
12:25 pm - 12:30 pm Discussion
12:30 pmLunch
1:30 pm - 4:00 pmFree Time
4:00 pm - 6:00 pmPoster Session II
6:00 pmDinner
7:00 pm - 7:30 pmBusiness Meeting
(Nominations for the next Vice Chair; Fill out Conference Evaluation Forms; Discuss future Site & Scheduling preferences; Election of the next Vice Chair)
7:30 pm - 9:30 pmPlaque Dynamics
Discussion Leader: Richard Lee (Brigham and Women's Hospital)
7:30 pm - 7:50 pm Hanjoong Jo (Emory)
"Bone morphogenetic proteins and shear stress"
7:50 pm - 8:00 pm Discussion
8:00 pm - 8:20 pm Guillermo Garcia-Cardena (Brigham and Women's Hospital)
"Transcriptional regulation by Klf2/4"
8:20 pm - 8:30 pm Discussion
8:30 pm - 8:50 pm Craig Simmons (University of Toronto)
"Biomechanical stimuli and cardiac valve pathobiology"
8:50 pm - 9:00 pm Discussion
9:00 pm - 9:10 pm Short Talk: Mete Civelek (University of Pennsylvania)
"Chronic endoplasmic reticulum stress in athero-susceptible arterial endothelium in vivo"
9:10 pm - 9:15 pm Discussion
9:15 pm - 9:25 pm Short Talk: Lisa Tannock (University of Kentucky)
"Serum amyloid A accelerates atherosclerosis development"
9:25 pm - 9:30 pm Discussion
9:30 pm Reception
THURSDAY
7:30 am - 8:30 amBreakfast
9:00 am - 12:30 pmAtherosclerosis Progression and Regression
Discussion Leaders: Elaine Raines (University of Washington) and Ed Fisher (New York University)
9:00 am - 9:20 am Ira Tabas (Columbia University)
"Mechanisms and consequences of efferocytosis in the progression of atherosclerosis"
9:20 am - 9:30 am Discussion
9:30 am - 9:50 am J.W. Tervaert (Cardiovascular Research Institute Maastricht)
"Acceleration of atherosclerosis and autoimmunity"
9:50 am - 10:00 am Discussion
10:00 am - 10:20 am Guo-Ping Shi (Brigham and Women's Hospital)
"Mast cell functions in cardiovascular diseases"
10:20 am - 10:30 am Discussion
10:30 am Coffee Break
11:00 am - 11:20 am Elaine Raines (University of Washington)
"Do proteases really break atherosclerotic plaques?"
11:20 am - 11:30 am Discussion
11:30 am - 11:50 am Ed Fisher (New York University)
"HDL and regression: regulation of macrophage migration and inflammatory state"
11:50 am - 12:00 pm Discussion
12:00 pm - 12:20 pm Collin Stultz (Massachusetts Institute of Technology)
"New insights into the mechanism of collagenolysis"
12:20 pm - 12:30 pm Discussion
12:30 pmLunch
1:30 pm - 4:00 pmFree Time
4:00 pm - 6:00 pmPoster Session II
6:00 pmDinner
7:30 pm - 9:30 pmSystems Biology of Atherosclerosis: "The Artery Wall and Beyond"
Discussion Leaders: Martha Cathcart (Cleveland Clinic) and Linda Demer (UCLA)
7:30 pm - 7:40 pm Brian Bennett (UCLA)
"Novel aystems genetic approach for identification of atherosclerotic susceptibly loci atherosclerotic susceptibly loci"
7:40 pm - 7:45 pm Discussion
7:45 pm - 8:05 pm Elizabeth Gold (Systems Biology Institute)
"Systems approach to understanding macrophage differentiation"
8:05 pm - 8:15 pm Discussion
8:15 pm - 8:35 pm Rita Upmacis (Weill Cornell Medical College)
"Nitrative and oxidative stress: thinking outside the plaque"
8:35 pm - 8:45 pm Discussion
8:45 pm - 9:20 pm Lecture in Honor of the Journal of Lipid Research 50th Anniversary:
Stan Hazen (Cleveland Clinic)
"Metabolomics studies implicate choline metabolism in cardiovascular disease pathogenesis"
9:20 pm - 9:30 pm Discussion
9:30 pm Reception
FRIDAY
7:30 am - 8:30 amBreakfast
9:00 amDepart

Funding for this conference was made possible (in part) by 1R13HL096204-01 from the National Institutes of Health, National Heart, Lung & Blood Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.